Clinical and genetic heterogeneity in nemaline myopathy - A disease of skeletal muscle thin filaments

Despina Sanoudou, Alan H. Beggs

Research output: Contribution to journalArticle

119 Citations (Scopus)

Abstract

The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.

Original languageEnglish
Pages (from-to)362-368
Number of pages7
JournalTrends in Molecular Medicine
Volume7
Issue number8
DOIs
Publication statusPublished - 21 Aug 2001
Externally publishedYes

Fingerprint

Nemaline Myopathies
Genetic Heterogeneity
Skeletal Muscle
Sarcomeres
Muscle Weakness
Counseling
Muscles
Genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Clinical and genetic heterogeneity in nemaline myopathy - A disease of skeletal muscle thin filaments. / Sanoudou, Despina; Beggs, Alan H.

In: Trends in Molecular Medicine, Vol. 7, No. 8, 21.08.2001, p. 362-368.

Research output: Contribution to journalArticle

@article{7847b41b1f9444ad8e9dc30fa30a1710,
title = "Clinical and genetic heterogeneity in nemaline myopathy - A disease of skeletal muscle thin filaments",
abstract = "The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.",
author = "Despina Sanoudou and Beggs, {Alan H.}",
year = "2001",
month = "8",
day = "21",
doi = "10.1016/S1471-4914(01)02089-5",
language = "English",
volume = "7",
pages = "362--368",
journal = "Trends in Molecular Medicine",
issn = "1471-4914",
publisher = "Elsevier Limited",
number = "8",

}

TY - JOUR

T1 - Clinical and genetic heterogeneity in nemaline myopathy - A disease of skeletal muscle thin filaments

AU - Sanoudou, Despina

AU - Beggs, Alan H.

PY - 2001/8/21

Y1 - 2001/8/21

N2 - The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.

AB - The term nemaline myopathy (NM) encompasses a heterogeneous group of disorders of primary skeletal muscle weakness characterized by the presence of nemaline rods in muscles of affected individuals. Disease severity is variable and unpredictable, with prognosis ranging from neonatal death to almost normal motor function. Recent advances in the identification of NM disease genes demonstrate that NM is a disease of the skeletal muscle sarcomere and, in particular, of the thin filaments. These findings are starting to alter the approach that neurologists and geneticists take to diagnosing and counseling patients with NM, and could lead to insights into specific directed therapies in the future.

UR - http://www.scopus.com/inward/record.url?scp=0034906020&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034906020&partnerID=8YFLogxK

U2 - 10.1016/S1471-4914(01)02089-5

DO - 10.1016/S1471-4914(01)02089-5

M3 - Article

VL - 7

SP - 362

EP - 368

JO - Trends in Molecular Medicine

JF - Trends in Molecular Medicine

SN - 1471-4914

IS - 8

ER -